Literature DB >> 12375242

A retrospective clinical and radiographic review of 173 hydroxyapatite-coated screw cups with 5- to 10-year follow-up, showing low revision rates for fixation failure.

C J Mann1, S McNally, E Taylor, J A N Shepperd.   

Abstract

We reviewed the midterm results of 173 hydroxyapatite-coated screw cups. The average follow-up was 6.5 years (range, 5-9 years). The follow-up rate was 93%. Patients were assessed using the Merle D'Aubigne-Postel clinical scoring scale and by radiographic review. Two patients had revision surgery for recurrent dislocation (1.2%), 3 patients were revised for aseptic loosening (1.7%), 1 patient underwent revision surgery because of deep prosthetic infection (0.6%), and 2 patients were revised for polyethylene wear without loosening (1.2%), which gave a total revision rate of 4.7%. The average postoperative Merle D'Aubigne-Postel scores were 5.7 for pain, 5.5 for range of motion, and 5.4 for function. Copyright 2002, Elsevier Science (USA)

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12375242     DOI: 10.1054/arth.2002.34825

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  3 in total

1.  Is the bone-bonding ability of a cementless total hip prosthesis enhanced by alkaline and heat treatments?

Authors:  Kazutaka So; Ayumi Kaneuji; Tadami Matsumoto; Shuichi Matsuda; Haruhiko Akiyama
Journal:  Clin Orthop Relat Res       Date:  2013-12       Impact factor: 4.176

2.  No improvement in long-term wear and revision rates with the second-generation Biomet cup (RingLoc) in young patients: 141 hips followed for median 12 years.

Authors:  Bart Boesenach; Huub J L van der Heide; Rob G H H Nelissen
Journal:  Acta Orthop       Date:  2011-11-09       Impact factor: 3.717

3.  Total hip arthroplasty using a three-dimensional porous titanium acetabular cup: an examination of micromotion using subject-specific finite element analysis.

Authors:  Takaki Miyagawa; Kazu Matsumoto; Shingo Komura; Haruhiko Akiyama
Journal:  BMC Musculoskelet Disord       Date:  2021-03-26       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.